JAMA. 2020 Jan 6.
- News & Events
Launched in January 2020, the H2020-funded PERMIT will develop recommendations for robust and reproducible personalised medicine research.
PERMIT brings together field experts, funding bodies, patient representative associations, medicine agencies, HTA authorities, and other key stakeholders from across Europe to collaborate in every stage of the project. The goal is to reach consensus and broad acceptability of the proposed methodological recommendations.
PERMIT aims to enhance personalised medicine research through various activities.
Literature mapping on methods in personalised medicine and gap analysis (foundation for WP3-6)
Recommendations on stratification cohort design, data collection, quality / traceability, management
Recommendations on the use of machine learning for stratification algorithms
Recommendations on translational research for treatment selection
Recommendations on the design of randomised trials in personalised medicine